A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Obnienie cinienia czsto pojawia si bardzo wczenie, zanim dojdzie do istotnego spadku masy ciaa
HUVECs were treated with individual mutant peptides (10 ng/mL) for 24 h, and cell proliferation was quantified via a CCK-8 assay
Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects
Acetaminophen is found in Tylenol and many cold and flu remedies
Adv Ther 39(6):24522467 Davies MJ et al (2015) Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial